Novos path forward on this issue, however, is a slog because unlike the shortage list, 353b requires that FDA implement the demonstrably difficult list by regulation. Moreover, the statute requires that FDA convene an advisory committee on compounding which shall include representatives from the National Association of Boards of Pharmacy, the United States Pharmacopeia, pharmacists with current experience and expertise in compounding, physicians with background and knowledge in compounding, and patient and public health advocacy organizations. See 21 USC 353b(c)
Maintenance of Certification in Anesthesiology and MOCA are registered certification marks of the American Board of Anesthesiology American Board of Internal Medicine (ABIM) Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.50 Medical Knowledge MOC points and patient safety MOC credit in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program
GLP-1 patches, on the other hand, are unregulated and may contain untested, unsafe ingredients
Developed initially to manage diabetes, glucagon-like peptide-1 (GLP-1) receptor agonists have skyrocketed in popularity since the US Food & Drug Administration first approved semaglutide (brand name Ozempic/Wegovy) for weight loss in 2021
